On Monday shares of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) closed at $12.37. Company’s EPS growth for next 5 years is recorded as 40.00%. Dipexium Pharmaceuticals Inc. (DPRX) on May 14, reported a loss of $4.2 million in its first quarter. TheRead More
On Monday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $2.42. On May 13, Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM), announced the appointment of Jeng-Dar Yang, Ph.D. to the position of Vice President of Pharmaceutical Development effective May 4, 2015. Dr. YangRead More
On Monday shares of Roundy’s, Inc. (NYSE:RNDY) closed at $4.49. Company’s sales growth for last 5 years was 0.60% and EPS growth for next 5 years is recorded as 10.00%. On May 18, Roundy’s, Inc. (NYSE:RNDY) announced that it hasRead More
On Monday shares of Regions Financial Corporation (NYSE:RF) closed at $10.21. Company’s sales growth for last 5 years was -7.40% and EPS growth for next 5 years is recorded as 6.03%. On May 13, Regions Financial Corporation (NYSE:RF) is scheduledRead More
On Monday shares of ImmuCell Corp. (NASDAQ:ICCC) closed at $8.03. Company’s sales growth for last 5 years was 11.10%. On May 12, ImmuCell Corporation (NASDAQ:ICCC), announced financial results for its first quarter ended March 31, 2015. Total sales increased 49%Read More
On Monday shares of Verastem, Inc. (NASDAQ:VSTM) closed at $8.74. Company’s EPS growth for next 5 years is recorded as 1.74%. On May 11, Verastem, Inc. (NASDAQ:VSTM), reported financial results for the first quarter ended March 31, 2015, and alsoRead More
On Monday shares of Micron Technology, Inc. (NASDAQ:MU) closed at $26.76. Company’s sales growth for last 5 years was 27.80% and EPS growth for next 5 years is recorded as 15.00%. Micron Technology (NASDAQ:MU)‘s stock had its “buy” rating reissuedRead More
On Monday shares of Lakeland Industries Inc. (NASDAQ:LAKE) closed at $10.47. Company’s sales growth for last 5 years was -2.10% and EPS growth for next 5 years is recorded as 10.00%. On May 18, Lakeland Industries, Inc. (NASDAQ: LAKE), announcedRead More
On Monday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $14.20. Sorrento Therapeutics (NASDAQ:SRNE)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainright in a research report issued on Friday. They currently have a $20.00 target priceRead More
On Monday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $3.34. May 15, CymaBay Therapeutics Inc. (NASDAQ:CBAY) announced that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 2015 UBS Global Healthcare ConferenceRead More
